Pramoxine hydrochloride 10 MG/ML Rectal Foam [Proctofoam] — RxCUI 828367
RxNorm drug concept · Semantic branded drug
RxCUI 828367
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI828367
Official namePramoxine hydrochloride 10 MG/ML Rectal Foam [Proctofoam]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProctofoam 1 % Rectal Foam; Proctofoam 10 MG/ML Rectal Foam
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)56 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pramoxine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Pramoxine is a local anesthetic, which means it temporarily numbs the area where you apply it. It works right at the skin's surface to block the sensation of pain and itching. It d...
- What exactly does pramoxine do — how does it stop the itching?
- It depends on which product you have. Most creams, sprays, and solutions are used up to 3 to 4 times daily. Some products, like Proctofoam for the rectal area, can be used up to 5...
- No. All pramoxine products are for external use only — that means the outside of the skin. Even products intended for the genital or rectal area, like the Terramed Intimate Wash or...
🕸️ Concept Web — How Pramoxine hydrochloride 10 MG/ML Rectal Foam [Pr... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pramoxine hydrochloride 10 MG/ML Rectal Foam [Proctofoam]
RxCUI 828367 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Pramoxine
34347IN -
Pramoxine hydrochloride
57555PIN
-
Pramoxine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Proctofoam
219426BN
-
Proctofoam
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pramoxine Rectal Foam
384612SCDF -
Pramoxine hydrochloride Rectal Foam
2647295SCDFP -
Pramoxine Rectal Product
1165742SCDG -
Pramoxine hydrochloride Rectal Product
2662694SCDGP -
Pramoxine Rectal Foam [Proctofoam]
362449SBDF -
Pramoxine hydrochloride Rectal Foam [Proctofoam]
2655765SBDFP -
Proctofoam Rectal Product
1180030SBDG -
Rectal Foam
317542DF - +1 more in this family
-
Pramoxine Rectal Foam
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pramoxine hydrochloride 10 MG/ML Rectal Foam
828365SCD -
Pramoxine hydrochloride 10 MG/ML
828361SCDC -
Pramoxine hydrochloride 10 MG/ML [Proctofoam]
828366SBDC
-
Pramoxine hydrochloride 10 MG/ML Rectal Foam
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pramoxine hydrochloride 10 MG/ML Rectal Foam
SCD · 828365 -
Pramoxine hydrochloride 10 MG/ML
SCDC · 828361 -
Pramoxine Rectal Foam
SCDF · 384612 -
Pramoxine hydrochloride Rectal Foam
SCDFP · 2647295 -
Pramoxine Rectal Product
SCDG · 1165742 -
Pramoxine hydrochloride Rectal Product
SCDGP · 2662694
Brand-Name Concepts
-
Pramoxine hydrochloride 10 MG/ML [Proctofoam]
SBDC · 828366 -
Pramoxine Rectal Foam [Proctofoam]
SBDF · 362449 -
Pramoxine hydrochloride Rectal Foam [Proctofoam]
SBDFP · 2655765 -
Proctofoam Rectal Product
SBDG · 1180030 -
Proctofoam
BN · 219426
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 828367 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00037-6823-15 | 1 CANISTER in 1 CARTON (0037-6823-15) / 15 g in 1 CANISTER | PROCTOFOAM NS | Viatris Specialty LLC | 2014-08-18 |
Observed labelers:
Viatris Specialty LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$7.1734
Range $7.1734–$7.1734
· middle 50% $7.1734–$7.1734
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.